[go: up one dir, main page]

AU2016219622A1 - Heterodimeric antibody FC-containing proteins and methods for production thereof - Google Patents

Heterodimeric antibody FC-containing proteins and methods for production thereof

Info

Publication number
AU2016219622A1
AU2016219622A1 AU2016219622A AU2016219622A AU2016219622A1 AU 2016219622 A1 AU2016219622 A1 AU 2016219622A1 AU 2016219622 A AU2016219622 A AU 2016219622A AU 2016219622 A AU2016219622 A AU 2016219622A AU 2016219622 A1 AU2016219622 A1 AU 2016219622A1
Authority
AU
Australia
Prior art keywords
methods
production
containing proteins
heterodimeric antibody
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016219622A
Inventor
Patrick Van Berkel
Ewald Van Den Bremer
Bart De Goeij
Aran Frank Labrijn
Joyce Meesters
Joost J. Neijssen
Paul Parren
Janine Schuurman
Jan Van De Winkel
Tom Vink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genmab AS
Original Assignee
Genmab AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013203221A external-priority patent/AU2013203221B2/en
Application filed by Genmab AS filed Critical Genmab AS
Priority to AU2016219622A priority Critical patent/AU2016219622A1/en
Publication of AU2016219622A1 publication Critical patent/AU2016219622A1/en
Priority to AU2018201503A priority patent/AU2018201503A1/en
Priority to AU2019283898A priority patent/AU2019283898C1/en
Priority to AU2022201608A priority patent/AU2022201608B2/en
Priority to AU2025237959A priority patent/AU2025237959A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Novel heterodimeric antibody-Fc-containing proteins, such as bispecific antibodies, and novel methods for producing such proteins.
AU2016219622A 2010-04-20 2016-08-24 Heterodimeric antibody FC-containing proteins and methods for production thereof Abandoned AU2016219622A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2016219622A AU2016219622A1 (en) 2010-04-20 2016-08-24 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2018201503A AU2018201503A1 (en) 2010-04-20 2018-03-01 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2019283898A AU2019283898C1 (en) 2010-04-20 2019-12-18 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2022201608A AU2022201608B2 (en) 2010-04-20 2022-03-08 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2025237959A AU2025237959A1 (en) 2010-04-20 2025-09-24 Heterodimeric antibody FC-containing proteins and methods for production thereof

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US61/326,082 2010-04-20
DKPA201000330 2010-04-20
DKPA201001066 2010-11-24
AU2013203221A AU2013203221B2 (en) 2010-04-20 2013-04-09 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2016219622A AU2016219622A1 (en) 2010-04-20 2016-08-24 Heterodimeric antibody FC-containing proteins and methods for production thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2013203221A Division AU2013203221B2 (en) 2010-04-20 2013-04-09 Heterodimeric antibody FC-containing proteins and methods for production thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2018201503A Division AU2018201503A1 (en) 2010-04-20 2018-03-01 Heterodimeric antibody FC-containing proteins and methods for production thereof

Publications (1)

Publication Number Publication Date
AU2016219622A1 true AU2016219622A1 (en) 2016-09-15

Family

ID=56898950

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2016219622A Abandoned AU2016219622A1 (en) 2010-04-20 2016-08-24 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2018201503A Abandoned AU2018201503A1 (en) 2010-04-20 2018-03-01 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2019283898A Active AU2019283898C1 (en) 2010-04-20 2019-12-18 Heterodimeric antibody FC-containing proteins and methods for production thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2018201503A Abandoned AU2018201503A1 (en) 2010-04-20 2018-03-01 Heterodimeric antibody FC-containing proteins and methods for production thereof
AU2019283898A Active AU2019283898C1 (en) 2010-04-20 2019-12-18 Heterodimeric antibody FC-containing proteins and methods for production thereof

Country Status (1)

Country Link
AU (3) AU2016219622A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006106905A1 (en) * 2005-03-31 2006-10-12 Chugai Seiyaku Kabushiki Kaisha Process for production of polypeptide by regulation of assembly
WO2009089004A1 (en) * 2008-01-07 2009-07-16 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects

Also Published As

Publication number Publication date
AU2018201503A1 (en) 2018-03-22
AU2019283898B2 (en) 2021-12-09
AU2019283898C1 (en) 2022-06-16
AU2019283898A1 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
EP4477668A3 (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
WO2010145792A8 (en) Bispecific antigen binding proteins
SG178886A1 (en) Humanized anti-cdcp1 antibodies
MX336682B (en) Antibodies against human csf-1r and uses thereof.
MX340558B (en) Bispecific antibodies comprising a disulfide stabilized - fv fragment.
MX356337B (en) Antibodies against human csf-1r and uses thereof.
WO2013060867A3 (en) Production of heterodimeric proteins
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
MX2019003427A (en) Cell culture compositions and methods for polypeptide production.
AU2014247175A8 (en) Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 and methods of use
MY170720A (en) Antibody formulations
WO2013188693A8 (en) Antigen binding constructs to cd3
MX359384B (en) Improved assembly of bispecific antibodies.
AU2009301431A8 (en) Bispecific anti-VEGF/anti-ANG-2 antibodies
EA201171148A1 (en) ANTI-TELE-ANTAGONIST, SPECIFIC FOR THE ALPHA-4-BETA-7 HETERODIMER
MX342034B (en) Monovalent antigen binding proteins.
WO2009114702A3 (en) Recombinant production of authentic human proteins using human cell expression systems
MX366112B (en) Cell culture media and methods of antibody production.
WO2012064836A9 (en) Methods and compositions for neural disease immunotherapy
WO2012068317A3 (en) Methods for producing recombinant proteins
EP4375371A3 (en) Methods for the manufacture of proteolytically processed polypeptides
WO2010121093A3 (en) Humanized antibody compositions and methods for binding lysophosphatidic acid
NZ629553A (en) Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
EP4458858A3 (en) Method for the production of immunoglobulin single variable domains
WO2010079510A3 (en) Anti-rhd monoclonal antibodies

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted